Previous 10 | Next 10 |
Motley Fool news releases related Motley Fool news releases and Motley Fool press releases from 07/10/24 07:30:00 on US and Canada Markets.
2024-07-10 07:30:00 ET The trend is not the friend for Baidu (NASDAQ: BIDU) shareholders. China's iconic search engine finds its stock trading 20% lower in the otherwise buoyant 2024, off a blistering 33% over the past year. Many Chinese investments have fallen out of favor lately, ...
2024-07-10 07:30:00 ET Palantir Technologies (NYSE: PLTR) has had a strong 2024, with the stock up more than 60% so far. That means it's more than halfway to a double, so the question becomes, could Palantir double over the entirety of 2024? While Palantir's business is strong, ...
2024-07-10 07:15:00 ET Amazon (NASDAQ: AMZN) is one of the latest additions to the $2 trillion valuation club. This exclusive group comprises only five companies, but these also happen to be some of the most dominant businesses on the globe. While many in this group have strong ...
2024-07-10 07:13:00 ET The market has soared since the beginning of 2023. The S&P 500 index has posted a total return level of 48% over that time frame, pushing the index's price-to-earnings ( P/E ) ratio of nearly 29. This is much higher than the long-term market average, w...
2024-07-10 06:53:00 ET Quantum computing expert IonQ (NYSE: IONQ) is going through a tricky growth spurt. First-quarter revenues rose by 77% year over year, but the company is burning lots of cash. Meanwhile, investors have turned away from the previously red-hot quantum computing i...
2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...
2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...
2024-07-10 06:23:00 ET Buying a stock on weakness can be a dangerous idea. Imagine a stock that you think may be a decent buy falls to a new 52-week low. Then a few weeks later, it hits a new low. Then another. And after a while of this tailspin, it's at a multiyear low. That's what m...
2024-07-10 06:15:00 ET If you buy and hold a quality stock for the long term, you expect to earn a good return. But often, I see investors dismiss valuations because the argument is that everything will sort itself out in the long run -- and that can be a dangerous assumption. If you bu...
2024-07-10 06:15:00 ET Equities performed well over the past few years, but that will be cold comfort to Fiverr 's (NYSE: FVRR) shareholders. The tech company has seen its shares plunge by a whopping 90% in the past three years -- an abysmal performance by almost any metric. One cou...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
11.79%Change Percent:
AvidXchange Holdings Inc. Company Name:
AVDX Stock Symbol:
NASDAQ Market:
avidxchange.com Website: